Jan Philipp Bewersdorf, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Jan Philipp Bewersdorf is an Assistant Professor of Medicine (Hematology) at Yale University. Following medical school training in Germany, he completed his Internal Medicine training at Yale - New Haven Hospital. After completion of residency, Dr. Bewersdorf pursued his fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center in New York before joining the faculty at Yale in July 2024. Dr. Bewersdorf is board-certified in Internal Medicine and Medical Oncology and board-eligible in Hematology.
His career as a clinician-scientist has been dedicated to myeloid malignancies spanning from myeloproliferative neoplasms to myelodysplastic syndromes and acute myeloid leukemia. Dr. Bewersdorf's work aims to combine basic and translational research with clinical and outcomes research to study those disorders from multiple angles. Inspired by the privilege of taking care of patients with myeloid neoplasms, he strives to advance patient care by conducting innovative clinical trials with a strong correlative component in collaboration with laboratory-based colleagues. He has developed and co-led several early phase clinical trials in myeloid malignancies and his research efforts have led to over 100 peer-reviewed publications to date including first-author publications in Lancet, Blood, Leukemia, and Lancet Haematology.
Dr. Bewersdorf has received several prestigious awards including the Edwards P. Evans Young Investigator Award, the Mortimer Lacher Fellowship from the Lymphoma Foundation, and multiple other achievement awards. He also serves on the editorial board and is a reviewer of several important hematology and oncology journals.
Education & Training
- Chief FellowMemorial Sloan Kettering Cancer Center (2024)
- FellowshipMemorial Sloan Kettering Cancer Center (2024)
- ResidentYale - New Haven Hospital (2021)
- ResidentLudwig-Maximilians-University Munich (2018)
- MDLudwig-Maximilians-University Munich (2017)
Activities
- Validation of the Composite Complete Response Definitions per IWG 2023 Criteria in Patients with Higher-Risk MDS Treated with Hypomethylating Agents – a Large, Multicenter, Retrospective Analysis from the VALIDATE DatabaseSan Diego, CA, United States 2023Annual Meeting American Society of Hematology
- Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1-Mutant Acute Myeloid LeukemiaNew Orleans, LA, United States 2022Annual Meeting American Society of Hematology
- Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid LeukemiaVirtual due to COVID 2021Annual Meeting American Society of Hematology
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Young Investigator Award | Edward P. Evans MDS Foundation | 2024 |
Mortimer J. Lacher Fellowship | Lymphoma Foundation | 2024 |
American Society of Hematology (ASH) Abstract Achievement Award | American Society of Hematology (ASH) | 2023 |
European Hematology Association Travel Award | European Hematology Association | 2023 |
Mortimer J. Lacher Fellowship | Lymphoma Foundation | 2023 |
American Society of Hematology (ASH) Abstract Achievement Award | American Society of Hematology (ASH) | 2022 |
American Society of Hematology (ASH) abstract achievement award | American Society of Hematology (ASH) | 2020 |
American Society of Hematology (ASH) Abstract Achievement Award | American Society of Hematology | 2019 |
Professional Service
Organization | Role | Date |
---|---|---|
Leukemia & Lymphoma | Reviewer | 2024 - Present |
Blood Advances | Reviewer | 2024 - Present |
Haematologica | Reviewer | 2023 - Present |
Leukemia Research | Reviewer | 2022 - Present |
Clinical Cancer Research | Reviewer | 2022 - Present |
Dutch Cancer Socity | Grant Reviewer | 2021 - Present |
Leukemia | Reviewer | 2021 - Present |
British Journal of Haematology | Reviewer | 2021 - Present |
American Journal of Hematology | Reviewer | 2021 - Present |
Therapeutic Advances in Hematology | Reviewer | 2021 - Present |
Journal of Clinical Medicine | Reviewer | 2021 - Present |
Expert Review of Anticancer Therapy | Reviewer | 2021 - Present |
Cancer | Reviewer | 2020 - Present |
Expert Reviews of Hematology | Reviewer | 2019 - Present |